Finance

Lists
ALLO:NASDAQ
Allogene Therapeutics Inc
2,12 $
+3,92%
(+0,080) 1D
27 там., 13:48:14 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLO...
Open
2,04 $
High
2,14 $
Low
2,00 $
Mkt. cap
732,44 млн
Avg. vol.
5,66 млн
Volume
3,49 млн
52-wk high
4,46 $
52-wk low
1,04 $
EPS
-0,67 $
Beta
0,48
Shares outstanding
345,49 млн
No. of employees
150
Open
2,04 $
High
2,14 $
Low
2,00 $
Mkt. cap
732,44 млн
Avg. vol.
5,66 млн
Volume
3,49 млн
52-wk high
4,46 $
52-wk low
1,04 $
EPS
-0,67 $
Beta
0,48
Shares outstanding
345,49 млн
No. of employees
150
News stories
From web sources and news partners
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, Калифорния, Америка Құрама Штаттары
Sector-
Websiteallogene.com
Analyst ratings
Based on 7 analysts giving stock ratings to ALLO in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ALLO in the last 3 months.
Highest
Current 2,12 $
14,00 $ (+560,38%)
Average
10,25 $ (+383,49%)
Lowest
8,00 $ (+277,36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Hold
Maintained
-
-
08/17/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/12/2026
Unknown Analyst
UBS
Buy
Reiterated
8,00 $
+277,4%
08/13/2026
Luca Issi
RBC Capital
Buy
Reiterated
9,00 $
+324,5%
08/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
10,00 $
+371,7%
08/13/2026
John Newman
Canaccord Genuity
Buy
Reiterated
14,00 $
+560,4%
08/13/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
7,00 $
+230,2%
05/14/2026
Roger Song
Jefferies
Buy
Maintained
10,00 $
+371,7%
04/15/2026
Jack Allen
Robert W. Baird
Buy
Maintained
9,00 $
+324,5%
04/14/2026
William Pickering
Bernstein
Hold
Maintained
3,85 $
+81,6%
04/14/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
11,00 $
+418,9%
04/16/2026
Reni Benjamin
Citizens JMP
Buy
Maintained
8,00 $
+277,4%
04/14/2026
Samantha Semenkow
Citi
Buy
Reiterated
4,00 $
+88,7%
04/09/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
10,00 $
+371,7%
03/13/2026
Last report
2026 ж. 12 там.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,13 $ / -0,15 $
+12,16%beat
Revenue / Est. (USD)
4,64 млн / 2,22 мың
+208 909,01%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
4,64 млн
Cost of goods sold
31,16 млн
28,63 млн
32,00 млн
30,72 млн
Cost of revenue
31,16 млн
28,63 млн
32,00 млн
30,72 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,74 млн
13,77 млн
14,09 млн
20,84 млн
Operating expense
13,74 млн
13,77 млн
14,09 млн
20,84 млн
Total operating expenses
44,90 млн
42,40 млн
46,09 млн
51,56 млн
Operating income
-44,90 млн
-42,40 млн
-46,09 млн
-46,92 млн
Other non operating income
-81,00 мың
247,00 м.
212,00 м.
-61,00 мың
EBT including unusual items
-41,40 млн
-38,81 млн
-42,61 млн
-42,68 млн
EBT excluding unusual items
-41,40 млн
-38,81 млн
-42,61 млн
-42,68 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-41,40 млн
-38,81 млн
-42,61 млн
-42,68 млн
Net profit margin
-
-
-
-919,76%
Earnings per share
-0,19
-0,17
-0,18
-0,13
Interest and investment income
3,93 млн
3,66 млн
3,57 млн
4,65 млн
Interest expense
-344,00 м.
-313,00 м.
-300,00 м.
-343,00 м.
Net interest expenses
3,58 млн
3,35 млн
3,27 млн
4,30 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-41,80 млн
-39,35 млн
-43,22 млн
-44,28 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары